Cost-Effectiveness Analysis Of Regorafenib In Gastrointestinal Stromal Tumours In England Using Crossover Adjustment Methods
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.2255
https://www.valueinhealthjournal.com/article/S1098-3015(16)33621-X/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2144
First Page :
A741
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33621-X&doi=10.1016/j.jval.2016.09.2255